NDC 71610-334

Pregabalin

Pregabalin

Pregabalin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Pregabalin.

Product ID71610-334_49d5064f-654b-4a6b-be12-e11523738b04
NDC71610-334
Product TypeHuman Prescription Drug
Proprietary NamePregabalin
Generic NamePregabalin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2019-07-19
Marketing CategoryANDA / ANDA
Application NumberANDA208677
Labeler NameAphena Pharma Solutions - Tennessee, LLC
Substance NamePREGABALIN
Active Ingredient Strength150 mg/1
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 71610-334-30

30 CAPSULE in 1 BOTTLE (71610-334-30)
Marketing Start Date2019-08-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71610-334-30 [71610033430]

Pregabalin CAPSULE
Marketing CategoryANDA
Application NumberANDA208677
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-15

NDC 71610-334-70 [71610033470]

Pregabalin CAPSULE
Marketing CategoryANDA
Application NumberANDA208677
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-15

NDC 71610-334-53 [71610033453]

Pregabalin CAPSULE
Marketing CategoryANDA
Application NumberANDA208677
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-15

NDC 71610-334-46 [71610033446]

Pregabalin CAPSULE
Marketing CategoryANDA
Application NumberANDA208677
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-15

Drug Details

Active Ingredients

IngredientStrength
PREGABALIN150 mg/1

OpenFDA Data

SPL SET ID:f33a9245-8a54-4d1c-8fbd-e00194fa9c93
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 577127
  • 483438
  • 483448
  • 483442
  • 483440
  • 483450
  • 483446
  • 483444

    • NDC Crossover Matching brand name "Pregabalin" or generic name "Pregabalin"

    NDCBrand NameGeneric Name
    61919-503PREGABALINPREGABALIN
    67877-457PregabalinPregabalin
    67877-469PregabalinPregabalin
    67877-468PregabalinPregabalin
    67877-466PregabalinPregabalin
    67877-465PregabalinPregabalin
    67877-464PregabalinPregabalin
    67877-467PregabalinPregabalin
    69097-962PregabalinPregabalin
    69097-959PregabalinPregabalin
    69097-958PregabalinPregabalin
    69097-957PregabalinPregabalin
    69097-961PregabalinPregabalin
    69097-956PregabalinPregabalin
    69097-954PregabalinPregabalin
    69097-955PregabalinPregabalin
    69238-1311PregabalinPregabalin
    69238-1315PregabalinPregabalin
    69238-1312PregabalinPregabalin
    69238-1314PregabalinPregabalin
    69238-1313PregabalinPregabalin
    69238-1310PregabalinPregabalin
    69238-1316PregabalinPregabalin
    69238-1317PregabalinPregabalin
    69539-018PregabalinPregabalin
    69539-013PregabalinPregabalin
    69539-015PregabalinPregabalin
    69539-017PregabalinPregabalin
    69539-016PregabalinPregabalin
    69539-012PregabalinPregabalin
    69539-014PregabalinPregabalin
    69539-011PregabalinPregabalin
    72205-013PregabalinPregabalin
    72205-015PregabalinPregabalin
    72205-017PregabalinPregabalin
    72189-023PREGABALINPREGABALIN
    72205-012PregabalinPregabalin
    72189-019PREGABALINPREGABALIN
    72205-014PregabalinPregabalin
    72205-011PregabalinPregabalin
    72189-020PREGABALINPREGABALIN
    72189-021PREGABALINPREGABALIN
    72205-018PregabalinPregabalin
    72205-016PregabalinPregabalin
    0071-1012LyricaPREGABALIN
    0071-1013LyricaPREGABALIN
    0071-1014LyricaPREGABALIN
    0071-1015LyricaPREGABALIN
    0071-1016LyricaPREGABALIN
    0071-1017LyricaPREGABALIN
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.